243 related articles for article (PubMed ID: 17527088)
41. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
[TBL] [Abstract][Full Text] [Related]
42. Mucinous adenocarcinoma with lepidic pattern and with K-RAS mutation in a newborn with antenatal diagnosis of congenital pulmonary airway malformation.
Stephanov O; Robert Y; De Fraipont F; Piolat C; Sartelet H
Histopathology; 2018 Feb; 72(3):530-531. PubMed ID: 28889407
[No Abstract] [Full Text] [Related]
43. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
44. Is congenital cystic adenomatoid malformation a premalignant lesion for pleuropulmonary blastoma?
Nasr A; Himidan S; Pastor AC; Taylor G; Kim PC
J Pediatr Surg; 2010 Jun; 45(6):1086-9. PubMed ID: 20620300
[TBL] [Abstract][Full Text] [Related]
45. An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation.
MacSweeney F; Papagiannopoulos K; Goldstraw P; Sheppard MN; Corrin B; Nicholson AG
Am J Surg Pathol; 2003 Aug; 27(8):1139-46. PubMed ID: 12883247
[TBL] [Abstract][Full Text] [Related]
46. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
[TBL] [Abstract][Full Text] [Related]
47. [Congenital cystic adenomatoid pulmonary malformation and cancer of lung. Molecular-genetic and immunohistochemical investigation of p53 gene, a regulator of cellular cycle].
Shestakova LA; Kogan EA; Kotlovskiĭ IuV
Arkh Patol; 2012; 74(1):19-22. PubMed ID: 22712299
[TBL] [Abstract][Full Text] [Related]
48. Inflammation can be present in infantile congenital cystic adenomatoid malformation of the lung.
Luzar B; Lamovec J
Adv Clin Path; 2002 Apr; 6(2):101-4. PubMed ID: 19753732
[TBL] [Abstract][Full Text] [Related]
49. Bronchioloalveolar carcinoma: a new cancer in Peutz-Jeghers syndrome.
von Herbay A; Arens N; Friedl W; Vogt-Moykopf I; Kayser K; Müller KM; Back W
Lung Cancer; 2005 Feb; 47(2):283-8. PubMed ID: 15639728
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathological and genetic characteristics of congenital cystic adenomatoid malformation of lung and its associated lung cancer in adults].
Liang L; Wu CY; Zhang LP; Hou LK; Dong ZW; Wu W; Huang Y; Xie HK
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):130-135. PubMed ID: 38281779
[No Abstract] [Full Text] [Related]
51. Multifocal synchronous mucinous adenocarcinomas arising in congenital pulmonary airway malformation: a case report with molecular study.
Kim MY; Kang CH; Park SH
Histopathology; 2014 Dec; 65(6):926-32. PubMed ID: 25066006
[TBL] [Abstract][Full Text] [Related]
52. Congenital cystic adenomatoid malformation type 4 and aneurysm of the vein of Galen: a rare coincidence or possibly related association.
Ozer E; Sanli A; Erbayraktar S; Ulukus C; Onen A
Pediatr Dev Pathol; 2004; 7(3):268-72. PubMed ID: 15022074
[TBL] [Abstract][Full Text] [Related]
53. Congenital cystic adenomatoid malformation of the lung: insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1.
Cangiarella J; Greco MA; Askin F; Perlman E; Goswami S; Jagirdar J
Mod Pathol; 1995 Dec; 8(9):913-8. PubMed ID: 8751331
[TBL] [Abstract][Full Text] [Related]
54. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of HOXB5, cyclin D1 and PCNA in congenital cystic adenomatoid malformation.
Wang X; Wolgemuth DJ; Baxi LV
Fetal Diagn Ther; 2011; 29(4):315-20. PubMed ID: 21228548
[TBL] [Abstract][Full Text] [Related]
56. Can K-ras-mutated atypical adenomatous hyperplasia be another precursor lesion for mucinous bronchioloalveolar carcinoma?
Garfield D
Am J Clin Pathol; 2008 Aug; 130(2):315-6; author reply 316. PubMed ID: 18697292
[No Abstract] [Full Text] [Related]
57. Bronchioloalveolar carcinoma: the case for two diseases.
Garfield DH; Cadranel J; West HL
Clin Lung Cancer; 2008 Jan; 9(1):24-9. PubMed ID: 18282354
[TBL] [Abstract][Full Text] [Related]
58. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
59. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
60. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
